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Spectral analysisa b s t r a c t
Objective: To investigate the EEG spectral changes induced during hemodialysis in patients with chronic
kidney disease (CKD), and to identify the risk factors associated with changes in the Central Nervous
System (CNS) during hemodialysis. Paradoxical neurological deterioration at the end of hemodialysis ses-
sions, known as dialysis disequilibrium syndrome (DDS) has been described, but previous studies on EEG
spectral changes during hemodialysis were controversial.
Methods: We performed quantitative EEG spectral analysis in 56 consecutive patients who underwent
hemodialysis. We compared EEG at the start and at the end of the hemodialysis, and we correlated the
spectral changes with the biochemical and clinical characteristics of the patients, using multivariate anal-
ysis.
Results: At the end of hemodialysis sessions, we found a significant increase in total EEG power, relative
power in delta frequency band and the ratio of delta-theta/alpha–beta power. EEG spectral changes were
associated with younger age, recent start of hemodialysis therapy, level of uremia and lower level of gly-
caemia.
Conclusions: Quantitative EEG spectral analysis showed that hemodialysis induced slowing of the EEG
background activity. These changes were associated with risk factors of DDS.
Significance: EEG spectral changes are potential biomarkers for monitoring CNS function during
hemodialysis.
 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
There have been controversial reports on EEG changes induced
during hemodialysis in patients with chronic kidney disease (CKD).
Early observational studies based on visual assessment of the
recordings, reported increase in the slow EEG frequency compo-
nents following hemodialysis: increase in theta activity and
appearance of high amplitude delta potentials (Kennedy et al.,
1963; Hampers et al., 1966). However, later studies using quantita-
tive spectral analysis methods were not able to confirm theseobservations (Kiley et al, 1976; Teschan et al., 1979; Basile et al,
1987; Arieff, 1994).
EEG changes induced during hemodialysis are important
because they may elucidate the pathomechanisms and highlight
the risk factors of a neurological complication occurring during
or immediately after hemodialysis, coined dialysis disequiliblium
syndrome (DDS) (Arieff, 1994; Patel et al., 2008; Zepeda-Orozco
and Quigley, 2012; Mistry, 2019). Paradoxically, patients may
show deterioration in their general condition toward the end of
or immediately following hemodialysis: headache, nausea and
vomiting, disorientation, asterixis and involuntary jerking move-
ments. In rare, severe cases, psychosis, generalized tonic-clonic sei-
zures and coma may be seen.
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ing hemodialysis, using spectral analysis methods, and to identify
risk factors associated with these changes.Table 1
EEG changes during hemodialysis, demonstrated by spectral analysis.
Parameter Start of hemodialysis End of hemodialysis p
Total Power [mV2] 14.54 (7.17, 20.7) 19.41 (12.98, 39.29) <0.001*
RP Delta [%] 0.32 ± 0.14 0.37 ± 0.19 0.035+
RP Theta [%] 0.14 (0.09, 0.2) 0.12 (0.09, 0.21) 0.967*
RP Alpha [%] 0.24 (0.14, 0.34) 0.2 (0.13, 0.32) 0.146+
RP Beta [%] 0.24 (0.19, 0.38) 0.23 (0.12, 0.32) 0.071+
Power Ratio 0.94 (0.57, 1.6) 1.08 (0.68, 2.04) 0.033*
RP = Relative Power; Power Ratio = (Delta + Theta)/(Alpha + Beta).
* Wilcoxon rank-sum test; + Student t test for paired samples.2. Methods
We included consecutive patients with CKD, undergoing
hemodialysis treatment three times per week. Patients gave their
informed consent and the study has been approved by the Ethics
Committee of Nefromed Dialysis Centers Cluj-Napoca.
Hemodialysis treatments were performed on 5008 Fresenius
machines with synthetic (helixone) high flux membranes with sur-
faces adapted to body weight and blood-flow to achieve Kt/V at
least 1.4.in 240 min. Kt/V is a way of measuring dialysis adequacy:
K stands for urea clearance, (volume of blood water cleared of urea
in time unit), t stands for time, V represents the distribution vol-
ume of urea, close of total water a patient’s body contains. One
third of the patients had online-hemodiafiltration targeting at least
21 l substitution per treatment. Bicarbonate solutions with glucose
were used: Na = 138 mmol/l, K = 2 mmol/l, Ca = 1,5 mg/dl, bicar-
bonate = 30–34 mEq/l, glucose = 1 g/l. Each hemodialysis session
had a duration of 210–270 min. At the end of the hemodialysis ses-
sions, patients generally experienced mild symptoms, such as
malaise and fatigue, but these were not severe and specific enough
to be considered as DDS.
EEGs were recorded for the entire duration of the hemodialysis
sessions (210–240 min), with an EBNeuro Galileo EEG equipment,
using scalp electrodes Ag/AgCl EasyCap (B10-S-200) placed accord-
ing to the international 10–20 system (Jasper 1958). Normal awake
activities such as speaking, eating or watching television were
allowed. The sampling frequency was 256 per second.
At the beginning and at the end of each hemodialysis sessions,
an experimenter verbally alerted the patients and, after a short
conversation with them, to keep vigilance, the patients were
required to stay relaxed with open eyes for 2–3 min. Patients and
EEGs were real-time monitored by the experimenter, to assess
the vigilance. Of these periods, where the patient was awake, with
open eyes, artifact-free epochs of 12 s (Kim, 2007) were identified
and subsequently analyzed.
EEG was evaluated by two board-certified clinical neurophysi-
ologists (BF and SB), in joint reading sessions, blinded to all clinical
data. Signals were digitally filtered 0.5–30 Hz. In order to minimize
any muscle artefacts, the central electrodes have been chosen for
quantitative analysis: C3 (central left) and C4 (central right). An
average of the values was calculated Cm = (C3 + C4)/2, for all the
further studies. We used common average reference. We analyzed
the following frequency bands: Delta (0.5–4 Hz), Theta (4–8 Hz),
Alpha (8–13 Hz) and Beta (13–30 Hz). We calculated the Total
Power (all bands), the Relative Power for each band (ratio of the
power in the frequency band and the Total Power), and the Power
Ratio between the slow and the high frequency powers: (Delta
+ Theta)/(Alpha + Beta).
We measured End-Tidal Carbon Dioxide (EtCO2) – CO2 concen-
tration of the expired air through Stardust nasal cannula, pulse,
EKG, respiratory rate (RR), pulsoximetry with a LifeSense Nonin
Capnograph. At the start of the hemodialysis sessions the body
mass was recorded, blood tests for Bicarbonate (ECO2), serum
Na, K, Ca, serum creatinine, glucose and urea were performed
and blood pressure (BP) was measured. The pH was recorded on
the left anatomical snuffbox with a portable dermatology pH-
meter Hanna Instruments (model HI 99181). The comorbidities
of the patients were registered.
For statistical analysis, we calculated the median (±standard
deviation) for those parameters with normal distribution and with
median 25th–75th percentile) for parameters that did not have147normal distribution. We used Kolmogorov-Smirnov test for assess-
ment of the normality of distribution. For each patient, two values
for the Alpha, Theta, Delta and Beta parameters were obtained
from the spectral analysis, one at the beginning and one at the
end of hemodialysis. The initial and final values were compared
by calculating the difference of each data-pair and comparing it
to zero, using Student test for paired samples when data had nor-
mal distribution, andWilcoxon test when distribution was not nor-
mal. In univariate analysis Pearson or Spearman coefficient of
correlation were used to analyze the relationship between two
quantitative variables. The univariate analysis was followed by
multivariate analysis. We used linear regression model for multi-
variate analysis. Each EEGmeasurement parameter was the depen-
dent variable, in a separate linear regression model. As
independent variables, we used the variables that proved to be sig-
nificantly correlated with the EEG measurement parameters in the
univariate analysis. Probability p less than 0.05 was consider sig-
nificant. The analysis was made using SPSS and Microsoft Excel.
3. Results
We included and analyzed 56 consecutive patients (20 female),
aged between 32 and 86 years (mean: 59.82 ± 12.76, median:
60.5 years). The patients had been treated with hemodialysis,
between 1 month and 192 months (mean: 61.41 ± 51.60, median:
42 months), and had the following comorbidities: high blood pres-
sure (50 patients; 50.0%), diabetes (18 patients; 32.1%), hep-
atopathies (10 patients; 17.9%), thyroid disease (8 patients;
14.3%), epilepsy (3 patients; 5.4%), history of traumatic brain injury
(3 patients; 5.4%). Supplementary document 1 shows the biochem-
ical and clinical parameters of the patients.
Hemodialysis resulted in a significant increase in Total EEG
Power (Table 1). Spectral analysis showed increase in Relative
Power of Delta band and an increase in the Power Ratio of the slow
EEG components toward the end of hemodialysis (Table 1). Multi-
variate analysis showed that EEG changes induced by hemodialysis
were associated with younger age, recent start of hemodialysis
therapy, uremia and lower level of glycaemia (Table 2).
4. Discussion
Using EEG spectral analysis, we confirmed the early observa-
tions, based on visual evaluation, that reported increase in the slow
EEG components, at the end of hemodialysis (Kennedy et al., 1963;
Hampers et al., 1966). Previous studies using spectral analysis were
not able to find such changes (Kiley et al, 1976; Teschan et al.,
1979; Basile et al, 1987; Arieff, 1994). This could be due to several
methodological aspects in the previous studies. EEG was analyzed
for epochs when the patients were performing mental arithmetic
exercises, which could have changed the EEG background activity.
The power ratio in previous studies was calculated for 3–7/7–
13 Hz, which does not include a significant portion (0.5–3.0 Hz)
of the delta band. By including the whole delta frequency band,
we found a significant increase in its relative power.
Table 2
Correlation between the biochemical and clinical parameters of the patients and the spectral EEG changes: significant correlation in univariate and multivariate analysis.
Dependent variable – EEG parameters
difference end-start of dialysis
Independent variable– Univariate analysis Multivariate linear analysis
Coefficient of correlation p b
(95% confidence interval)
p
Total Power Age 0.39 0.003 1.456 (2.734; 0.179) 0.026
Bicarbonate 0.28 0.041 –
Urea 0.37 0.005 –
Delta Relative Power Total duration of dialysis (months) 0.34 0.011 – –
Glycemia 0.34 0.013 0.001 (0.002; 0) 0.036
BW 0.31 0.020 – –
Theta Relative Power Age 0.27 0.044 0.002 (0.003; 0) 0.030
Total duration of dialysis (months) 0.32 0.015 0.001 (0.001; 0) 0.011
Alpha Relative Power Glycemia* 0.38 0.004 –
Body weight 0.29 0.030 –
Beta Relative Power Glycemia 0.27 0.047 0.001 (0; 0.001) 0.047
Power Ratio Age 0.28 0.039 – –
Glycemia* 0.34 0.012 – –
Urea 0.41 0.002 0.033 (0.008; 0.058) 0.011
* Nonlinear relationship.
B. Florea, R. Orasan, C. Budurea et al. Clinical Neurophysiology Practice 6 (2021) 146–148Since 19600, hemodialysis has proven a lifesaving treatment for
patients with CKD. However, a paradoxical change in neurological
status was noted in some patients, from the early days of
hemodialysis. This deterioration consisted of headache, dizziness,
nausea, vomiting, muscular cramps, tremor, convulsions, and
altered states of consciousness were described as dialysis disequi-
librium syndrome (DDS) (Arieff, 1994; Patel et al., 2008; Zepeda-
Orozco and Quigley, 2012; Mistry, 2019). These unfavorable
changes occurred especially in the first dialysis sessions and
appeared when the correction of some biochemical parameters
(especially urea) was too rapid. Hence, it was hypothesized that
DDS was caused by cerebral edema and increased intracranial
pressure, due to difference in osmolality between the rapidly dia-
lyzed serum and the CSF that was lagging behind (Kennedy et al.,
1963; Port et al., 1973).
We found that EEG spectral changes induced by hemodialysis
were associated with younger age, recent start of hemodialysis
therapy and with the level of uremia, which are similar to the risk
factors for DSS mentioned above (Arieff, 1994; Patel et al., 2008). In
addition, we found that lower glycaemia before hemodialysis was
also associated with increase in delta relative power. It is well doc-
umented that hypoglycemia causes diffuse EEG slowing and lower
glycaemia levels could predispose patients with CKD to the spec-
tral changes during hemodialysis.
When using modern dialysis methods, clinically manifest DDS
is a rare phenomenon. Although our patients generally experienced
mild symptoms, such as malaise and fatigue at the end of the dial-
ysis sessions, these were not severe and specific enough to be con-
sidered as DDS. However, we found significant spectral changes
(slowing) after hemodialysis, and these changes were associated
with the same risk factors that previously were reported for DSS,
suggesting that the spectral changes revealed the pathomecha-
nisms of CNS changes induced by dialysis.
5. Conclusions
We found that hemodialysis lead to slowing of the EEG back-
ground activity and increase in the relative power in delta fre-
quency band. This is a potential biomarker for quantifying
functional changes in the Central Nervous System during
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